Ohio gets $15.6M in pharma company settlement - Business First of Columbus:

viningocouqyl1601.blogspot.com
million through a multi-million-dollar settlement with a globalpharmaceutical company. Attorneyt General Marc Dann's office said Friday that Ohio will receive its portiojn of thetotal settlement, valued at $403 milliojn plus interest, along with states across the countr y from New York-based (NYSE:BMY) Dann, along with Medicaid fraufd units in four other claimed that Bristol-Myers allegedly overcharged Medicai d programs through inaccurate illegally marketed an anti-psychotic drug and induced physicians and pharmacistz to prescribe and dispense drugs against regulations.
The group also claimefd Bristol-Myers allegedly inaccurately reported prices forantidepressant Serzone, leadingg to the state receiving fewer rebates than it was eligibles for. The alleged activity took placse between 2002and 2005, said Ted Hart, a spokesmab for Dann's office. In addition to payinh states' Medicaid programs, Bristol-Myers is paying about $112 million to the federalo Medicare program and publiclyfunded hospitals, Hart The settlement comes weeks after the attorney general's office announced it received about $676,00 through a $182.
8 million settlement with Paris-based Stateas involved in that settlement similarly claimed the company allegedly inflateed prices of an anti-nausea drug it sold. Ohio'sd Medicaid program, started in 1968, assists 1.7 million Ohioanse a month on average, and about 2.2 million throughoutt the year. The $13.3 billion program, which takez up about a quarterd ofthe state's annual budget, servesa children and adults in low-income Ohio families.